CTLA4 and intrahepatic cholangiocarcinoma: In a mouse model experiment for intrahepatic cholangiocarcinoma, the therapeutic approach involved pre-treatment with a CTLA-4 inhibitor and platinum-based chemotherapy, followed by administration of a PD-1 inhibitor.